Results
|
11061.
|
|
|
11062.
|
|
|
11063.
|
|
|
11064.
|
|
|
11065.
|
|
|
11066.
|
|
|
11067.
|
|
|
11068.
|
|
|
11069.
|
|
|
11070.
|
Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses. [electronic resource] by
- Pavey, T
- Hoyle, M
- Ciani, O
- Crathorne, L
- Jones-Hughes, T
- Cooper, C
- Osipenko, L
- Venkatachalam, M
- Rudin, C
- Ukoumunne, O
- Garside, R
- Anderson, R
Producer: 20130409
In:
Health technology assessment (Winchester, England) vol. 16
Availability: No items available.
|
|
11071.
|
|
|
11072.
|
|
|
11073.
|
|
|
11074.
|
|
|
11075.
|
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country. [electronic resource] by
- Toy, Mehlika
- Onder, Fatih Oguz
- Idilman, Ramazan
- Kabacam, Gokhan
- Richardus, Jan Hendrik
- Bozdayi, Mithat
- Akdogan, Meral
- Kuloglu, Zarife
- Kansu, Aydan
- Schalm, Solko
- Yurdaydin, Cihan
Producer: 20130124
In:
The European journal of health economics : HEPAC : health economics in prevention and care vol. 13
Availability: No items available.
|
|
11076.
|
|
|
11077.
|
|
|
11078.
|
|
|
11079.
|
|
|
11080.
|
|